Amundi’s Core Scientific CORZ Stock Holding History

Amundi’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$424K	Buy	16,572 +6,358	+62%	+$150K	﹤0.01%	1710
2026 Q1	$153K	Buy	+10,214	New	+$174K	﹤0.01%	1918

Other funds holding CORZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Amundi's CORZ Position: Q2 2026 in Review

Amundi increased its Core Scientific (CORZ) stake by 62% in Q2 2026, buying an estimated $150K and bringing the position to 16,572 shares worth $424K. The position accounts for ﹤0.01% of the portfolio, ranked #1710.

Amundi first reported a position in CORZ in Q1 2026 and has held it in 2 quarters since. 413 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

Amundi held 16,572 shares of Core Scientific worth $424K as of Q2 2026.
Amundi bought 6,358 Core Scientific shares in Q2 2026, an estimated $150K.
Core Scientific made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1710 holding.
Amundi first reported a position in Core Scientific in Q1 2026 and has held it in 2 quarters since.
413 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.